Acquiring Company
Aurobindo Pharma Ltd
Acquired Company
A1 Biochem Group
United States
HyderabadManufacturingBiotechnologyPharmaceuticalBiotechnologyPharmaceuticalDescription
Aurobindo Pharma has successfully acquired the contract research services division of A1 Biochem Group. This acquisition allows Aurobindo's subsidiary, Apitoria Pharma, to secure an 80 percent stake in A1 Biochem Labs India, enhancing its service capabilities. The move is part of Aurobindo's strategy to expand into integrated contract research, development, and manufacturing services within the biopharmaceutical sector.
Fundz sees it the moment Aurobindo Pharma Ltd makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Frequently asked
Who acquired A1 Biochem Group?
A1 Biochem Group was acquired by Aurobindo Pharma Ltd, based in United States. The deal was reported on October 3, 2026. Aurobindo Pharma is a global pharmaceutical company headquartered in India. It develops, manufactures, and markets a wide range of generic pharmaceuticals and active pharmaceutical ingredients. Aurobindo Pharma Ltd is privately held and operates in Manufacturing.
When did Aurobindo Pharma Ltd acquire A1 Biochem Group?
Aurobindo Pharma Ltd's acquisition of A1 Biochem Group was reported on October 3, 2026. Aurobindo Pharma has successfully acquired the contract research services division of A1 Biochem Group. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does A1 Biochem Group do?
A1 Biochem Group is a Contract Research Organization (CRO) that offers comprehensive chemistry services to pharmaceutical companies and academic institutions. It is privately held, operating in Biotechnology, and is based in Hyderabad.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.